Therapeutic Potential of MicroRNA: A New Target to Treat Intrahepatic Portal Hypertension?

Therapeutic Potential of MicroRNA: A New Target to Treat Intrahepatic Portal Hypertension?

Intrahepatic portal hypertension accounts for most of the morbidity and mortality encountered in patients with liver cirrhosis, due to increased portal inflow and intrahepatic vascular resistance. Most treatments have focused only on portal inflow or vascular resistance. However, miRNA multitarget r...

Full description

Bibliographic Details
Main Authors:	Can-Jie Guo, Qin Pan, Hua Xiong, Yu-Qi Qiao, Zhao-Lian Bian, Wei Zhong, Li Sheng, Hai Li, Lei Shen, Jing Hua, Xiong Ma
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2014/797898

Similar Items

Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
by: Xuefeng Luo, et al.
Published: (2014-01-01)

Therapeutic effect and safety of transjugular intrahepatic portosystemic shunt in patients with primary biliary cirrhosis and portal hypertension
by: ZHANG Wei, et al.
Published: (2016-02-01)

Transjugular Intrahepatic Portosystemic Shunt Versus Surgical Shunting in the Management of Portal Hypertension
by: Long Huang, et al.
Published: (2015-01-01)

Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience
by: Yun Chen, et al.
Published: (2019-12-01)

The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status
by: Gilles Pomier-Layrargues, et al.
Published: (2012-01-01)

Transjugular intrahepatic portosystemic shunt for repeated bleeding of hemorrhoids caused by severe portal hypertension with ectopic varices: A case report
by: Qin Shi, et al.
Published: (2020-09-01)

Retrospective Study of Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhotic Portal Hypertension
by: Sara Santos, et al.
Published: (2020-06-01)

Transjugular intrahepatic portosystemic shunt creation for portal hypertension in patients with hepatocellular carcinoma: A systematic review
by: He Zhao, et al.
Published: (2018-10-01)

Efficacy and safety of laparoscopic splenectomy for hypersplenism secondary to portal hypertension after transjugular intrahepatic portosystemic shunt
by: Yingying Li, et al.
Published: (2021-02-01)

Advances in transjugular intrahepatic portosystemic shunt and its application in treatment of cirrhotic portal hypertension
by: XIAO Jiangqiang, et al.
Published: (2016-02-01)

Retrospective study of hepatic encephalopathy by different transjugular intrahepatic portosystemic shunt ways in portal hypertension
by: Xin Huo, et al.
Published: (2019-01-01)

Assessment of intrahepatic blood flow by Doppler ultrasonography: Relationship between the hepatic vein, portal vein, hepatic artery and portal pressure measured intraoperatively in patients with portal hypertension
by: Yuan Lijun, et al.
Published: (2011-07-01)

Rapamycin Attenuates Splenomegaly in both Intrahepatic and Prehepatic Portal Hypertensive Rats by Blocking mTOR Signaling Pathway.
by: Yunyang Chen, et al.
Published: (2016-01-01)

Successful surgical treatment for intrahepatic arterioportal fistula with severe portal hypertension: a case report
by: Hideyuki Takata, et al.
Published: (2019-04-01)

P-118 NONINVASIVE PARAMETERS OF PREDICTORS OF ESOPHAGEAL VARICES (EV) IN CHILDREN WITH INTRAHEPATIC PORTAL HYPERTENSION
by: Marina R. Adam, et al.
Published: (2021-09-01)

Intrahepatic portal-venous shunts during PVE
by: Sreeja Sanampudi, BS, et al.
Published: (2018-10-01)

Intrahepatic portal vein aneurysm in an asymptomatic patient
by: Mehmet Gumus, et al.
Published: (2010-04-01)

Advances in therapeutic options for portal hypertension
by: Marina Vilaseca, et al.
Published: (2018-11-01)

Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis.
by: Jin-Hang Gao, et al.
Published: (2013-01-01)

Are TIPS Tops in the Treatment of Portal Hypertension? A Review on the Use and Misuse of Transjugular Intrahepatic Portosystemic Shunts
by: Richard K Sterling, et al.
Published: (2000-01-01)

Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data
by: Hyung Ki Kim, et al.
Published: (2014-03-01)

Association between splenectomy and portal hypertension in the development of pulmonary hypertension
by: Li Huang, et al.
Published: (2020-03-01)

Intrahepatic Portal Vein Aneurysm with Concurrent Hepatocellular Carcinoma
by: Mohammad Hanafiah, et al.
Published: (2016-02-01)

Intrahepatic portal vein aneurysm with concurrent hepatocellular carcinoma
by: Hanafiah, M., et al.
Published: (2016)

The Serum microRNA Profile of Intrahepatic Cholestasis of Pregnancy: Identification of Novel Noninvasive Biomarkers
by: Ping Zou, et al.
Published: (2018-11-01)

Portal Hypertension
by: Mingyu Sun, et al.
Published: (2018-01-01)

Therapeutic strategy for gastroesophageal variceal bleeding of portal hypertension
by: TIAN Xiangguo
Published: (2015-03-01)

Haemodynamic assessment and therapeutic studies in portal hypertension and ascites
by: Stanley, Adrian John
Published: (1998)

Mortality and complications in patients with portal hypertension who underwent transjugular intrahepatic portosystemic shunt (TIPS) - 12 years experience
by: Fernanda Ribeiro Funes, et al.
Published: (2012-06-01)

Refractory portal hypertension complications successfully managed by parallel transjugular intrahepatic portosystemic shunt (TIPS): a case report
by: De Boo, D.W, et al.
Published: (2022)

Value of indocyanine green retention rate at 15 minutes in predicting the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in liver cancer patients with portal hypertension
by: WANG Zhong
Published: (2020-09-01)

Combination therapy using PSE and TIO ameliorates hepatic encephalopathy due to intrahepatic portosystemic venous shunt in idiopathic portal hypertension
by: Seiichiro Kojima, et al.
Published: (2016-09-01)

Studies on Disturbances of the Intrahepatic Portal Flow, after the Ligation of the Hepatic Arteries
by: Miyawaki, Hidegoshi
Published: (2016)

Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma.
by: Camilo Correa-Gallego, et al.
Published: (2016-01-01)

Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension
by: Wolfgang Kreisel, et al.
Published: (2020-08-01)

Diagnostic and therapeutic features of small bowel involvement in portal hypertension
by: Juan Egea-Valenzuela, et al.

THERAPEUTIC MANAGEMENT OF INTRAHEPATIC CHOLESTASIS OF PREGNANCY
by: Olga CERNEȚCHI, et al.
Published: (2019-07-01)

Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma
by: LIN Jian, et al.
Published: (2021-03-01)

Transsplenic portal vein reconstruction–transjugular intrahepatic portosystemic shunt in a patient with portal and splenic vein thrombosis
by: Jason T. Salsamendi, MD, et al.
Published: (2016-09-01)

MicroRNA let-7a: a novel therapeutic candidate in prostate cancer
by: Xiao-Qin Wu, et al.
Published: (2014-04-01)